Phase III study comparing maintenance by pemetrexed or gemcitabine to surveillance in elderly patient (≥ 70 year old) with advanced Non Small Cell Lung Cancer controlled by induction chemotherapy
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 28 Oct 2016
At a glance
- Drugs Gemcitabine (Primary) ; Pemetrexed (Primary) ; Carboplatin; Paclitaxel
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms MODEL
- 24 Oct 2016 Status changed from recruiting to active, no longer recruiting.
- 09 Mar 2016 Planned number of patients changed from 546 to 600, as reported by ClinicalTrials.gov record.
- 09 Mar 2016 Planned End Date changed from 1 Apr 2020 to 1 Dec 2018, as reported by ClinicalTrials.gov record.